BCI Payer Education
Dr Stephen C. Malamud and Dr Susan K. Boolbol discuss payer adoption of the Breast Cancer IndexSM (BCI) to ensure patient access and cost reimbursement.
Video Categories: PMO Interview with the Innovator Series: Volume 8PMO Interview with the Innovator Series: Volume 8
BCI and Adherence
Dr Stephen C. Malamud and Dr Susan K. Boolbol discuss the importance of using a clinically validated test such as the Breast Cancer IndexSM (BCI) and its impact on patient confidence in their treatment plan.
Video Categories: PMO Interview with the Innovator Series: Volume 8BCI Affects and Survivorship
Dr Susan K. Boolbol talks about the importance of objective evidence provided by the Breast Cancer IndexSM (BCI) in treatment decision making.
Video Categories: PMO Interview with the Innovator Series: Volume 8Benefits of Breast Cancer Index
Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.
Video Categories: PMO Interview with the Innovator Series: Volume 8When to Use Breast Cancer Index
Dr Stephen C. Malamud and Dr Susan K. Boolbol discuss the circumstances in which they would use the Breast Cancer IndexSM (BCI) to assist in determining whether to extend the adjuvant therapy of women with breast cancer beyond 5 years.
Video Categories: PMO Interview with the Innovator Series: Volume 8